Tea from Technical and Medicinal Hemp - recipe

01/20/2017 8 min read

Tea from Technical and Medicinal Hemp on Prescription

Preparing hemp tea is not complicated - the healing effects are quite significant!

Legal status of cannabis in the European Union (as of 25 September 2026)

The EU has no single cannabis law: it sets a common framework for hemp farming, trade and drug trafficking, while recreational use is regulated by each Member State.
CBD lawfully produced in one Member State may in principle be sold in another; a national ban is allowed only if it is suitable to protect public health and does not go beyond what is necessary. The Court held that such CBD is not a narcotic drug under the 1961 Single Convention (Articles 34 and 36 TFEU, Case C-663/18 Kanavape, paras 76 and 96).
Industrial hemp qualifies for CAP direct payments only if the THC content of the variety does not exceed 0.3 % (Art. 4(4) Regulation (EU) 2021/2115); THC control methods are set by the Commission (Art. 60(4)(a) Regulation (EU) 2021/2116).
Member States may restrict how hemp is grown, for example ban indoor hydroponic cultivation, if the restriction is suitable and proportionate for protecting public health (Case C-793/22 Biohemp Concept, 4 October 2024).
Member States must make intentional unlawful cultivation of cannabis plants and drug trafficking a criminal offence (Art. 2(1)(b) Framework Decision 2004/757/JHA, as quoted in Case C-271/23).
Rules on recreational cannabis differ widely: Germany allows adults to possess up to 25 g in public, 50 g at home and three plants (§ 3 and § 9 KCanG), while in Czechia personal use becomes a criminal offence only above 5 plants, 200 g at home or 50 g elsewhere, and plants with up to 1 % THC are excluded (§ 285 Czech Criminal Code).

“Články 34 a 36 SFEU musí být vykládány v tom smyslu, že brání vnitrostátní právní úpravě, která zakazuje uvádět na trh CBD, který je legálně vyprodukován v jiném členském státě, v případě, že je extrahován z celé rostliny cannabis sativa, a nikoli pouze z jejích vláken a semen, ledaže je tato právní úprava s to zaručit naplnění cíle ochrany veřejného zdraví a nepřekračuje meze toho, co je k dosažení tohoto cíle nezbytné.”
[Translation: “Articles 34 and 36 TFEU must be interpreted as precluding national legislation which prohibits the marketing of CBD lawfully produced in another Member State when it is extracted from the Cannabis sativa plant in its entirety and not solely from its fibre and seeds, unless that legislation is appropriate for securing the attainment of the objective of protecting public health and does not go beyond what is necessary for that purpose.”]
Court of Justice of the European Union, 19 November 2020, Case C-663/18 (Kanavape)

This overview is based on legislation and case law in the legal database Europaius. It is not legal advice.

Cannabis Genetics: High-Quality Collector Material

Collector-worthy cannabis seeds are among the most fascinating genetic materials in the plant kingdom. These unique botanical specimens offer collectors the opportunity to study and preserve extraordinary aroma profiles, complex chemical compositions, and genetic traits that have developed over millennia.

The world of cannabis genetics can essentially be divided into two main categories of collector material: industrial hemp varieties with low THC content and medicinal genetics with more complex cannabinoid profiles. Both types display characteristic aromatic properties and chemical compositions that make them highly prized specimens among specialized collectors.

Industrial Hemp Seeds: Chemical and Aromatic Profile

Industrial hemp genetics stand out for their exceptional content of CBD (cannabidiol), a non-psychoactive phytocannabinoid, which is also found in other plants such as coneflower. These collector-worthy strains are distinguished by the development of unique terpene profiles, including myrcene, limonene, and pinene, which create complex and refined aroma bouquets.

The chemical profile of these genetics typically shows CBD concentrations that can reach 15–20%, while THC content stays below 0.3%. This particular composition makes them especially prized specimens for collectors wishing to study the non-psychoactive properties of cannabis.

Extracting aromatic compounds from these genetics allows for the analysis of terpenes such as beta-caryophyllene, known for its characteristic organoleptic properties, as well as humulene, which lends these collector-worthy strains their typical herbal notes.

Botanical Characteristics of Hemp Strains

These genetics are characterized by the development of robust plant structures with deep green leaves and abundant trichomes. The genetic material of these strains has been selected over generations to optimize the production of specific aromatic compounds, resulting in plants that can reach considerable heights and develop extensive root systems.

Medicinal Genetics: Complex Cannabinoid Composition

Collector-worthy medicinal strains display more diverse and complex chemical profiles. These genetics have been developed to express specific ranges of cannabinoids, including THC, CBD, CBG (cannabigerol), and CBN (cannabinol), each contributing to the strain's unique characteristics.

The process of decarboxylation is fundamental to understanding these genetics. Under natural conditions, these plants produce acidic forms of cannabinoids (THCA, CBDA), which convert into their active forms through heat or time. This chemical transformation is crucial for studying the full aromatic properties of these collector-worthy strains.

Medicinal genetics typically develop more complex terpene profiles, including compounds such as terpinolene, linalool, and ocimene. These aromatic elements create what is known as the "entourage effect," a chemical synergy that determines the unique characteristics of each collector-worthy strain.

Studying Aroma Profiles in Specialized Collections

Specialized collectors particularly value genetics that express unique aroma profiles. Some strains develop intense citrus notes due to high limonene concentrations, while others exhibit earthy and spicy aromas thanks to the presence of beta-caryophyllene and myrcene.

Proper storage of these collector-worthy seeds requires specific temperature and humidity conditions to preserve the viability of the genetic material and maintain its potential aromatic properties. Experienced collectors store their specimens in airtight containers, in cool, dry places, protected from direct light.

Analysis and Preservation Methods for Genetic Material

The analysis of cannabinoids in collector-worthy genetic material has advanced significantly with the development of sophisticated chromatographic techniques. Collectors can now have detailed chemical profiles of their specimens created, determining precise concentrations of various active compounds.

High-performance liquid chromatography (HPLC) makes it possible to determine not only the levels of the major cannabinoids, but also less prevalent compounds such as CBC (cannabichromene) and CBDV (cannabidivarin), which contribute to the unique characteristics of each collector-worthy genetic.

For long-term preservation, experts recommend storage techniques that include the use of desiccants, vacuum containers, and strict temperature control. These methods ensure that the genetic material retains its aromatic potential and chemical properties over extended periods.

Documentation and Cataloguing of Genetics

A serious collection of cannabis genetics requires detailed documentation that includes the origin of each strain, its characteristic aromatic properties, the expected cannabinoid profile, and any information about its genetic lineage. This information is essential for understanding the scientific and collector value of each specimen.

Experienced collectors keep records that include detailed photographs of the seeds, notes on color and size variations, and any notable morphological features. This documentation not only preserves valuable information but also contributes to scientific knowledge of cannabis genetic diversity.